🇺🇸 FDA
Patent

US 8722738

Acetycysteine compositions and methods of use thereof

granted A61KA61K31/197A61K31/198

Quick answer

US patent 8722738 (Acetycysteine compositions and methods of use thereof) held by Cumberland Pharmaceuticals Inc. expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cumberland Pharmaceuticals Inc.
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/197, A61K31/198, A61K47/02, A61K9/0019